tradingkey.logo

Niagen Bioscience Inc <NAGE.OQ> expected to post earnings of 2 cents a share - Earnings Preview

ReutersMay 5, 2025 8:20 PM
  • Niagen Bioscience Inc NAGE.OQ NAGE.O is expected to show a rise in quarterly revenue when it reports results on May 7 for the period ending March 31 2025

  • The Los Angeles California-based company is expected to report a 22.3% increase in revenue to $27.1 million from $22.15 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Niagen Bioscience Inc is for earnings of 2 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Niagen Bioscience Inc is $8.05​, above​ its last closing price of $8.00. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

0.02

0.02

0.09

Beat

350

Sep. 30 2024

0.01

0.00

0.02

Beat

500.6

Jun. 30 2024

-0.02

-0.02

0.00

Beat

100​

Mar. 31 2024

-0.02

-0.02

-0.01

Beat

40

​​Dec. 31 2023

-0.03

-0.03

0.00

Beat

100

Sep. 30 2023

-0.03

-0.03

-0.01

Beat

69.2​

Jun. 30 2023

-0.04

-0.04

-0.03

Beat

20

Mar. 31 2023

-0.05

-0.05

-0.03

Beat

37.5

This summary was machine generated May 5 at 20:20 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI